COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 646: Articles 6451-6460  | Next

Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1).
Beraud, G., Bouetard, L., Civljak, R., Michon, J., Tulek, N., Lejeune, S., Millot, R., Garchet-Beaudron, A., Lefebvre, M., Velikov, P., Festou, B., Abgrall, S., Lizatovic, I. K., Baldolli, A., Esmer, H., Blanchi, S., Froidevaux, G., Kapincheva, N., Faucher, J.-F., Duvnjak, M., Afsar, E., Svitek, L., Yarimoglu, S., Yarimoglu, R., Janssen, C., EPAULARD, o.
10.1101/2022.10.23.22281414 — Posted: 2022-10-25
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with critical COVID-19
Matuozzo, D., Talouarn, E., Marchal, A., Manry, J., Seeleuthner, Y., Zhang, Y., Bolze, A., Chaldebas, M., Milisavljevic, B., Zhang, P., Gervais, A., Bastard, P., Asano, T., Bizien, L., Barzaghi, F., Abolhassani, H., Abou Tayoun, A., Aiuti, A., Alavi Darazam, I., Allende, L., Alonso-Arias, R., Arias, A. A., Aytekin, G., Bergman, P., Bondesan, S., Bryceson, Y., Bustos, I., Cabrera-Marante, O., Carcel, S., Carrera, P., Casari, G., Chaibi, K., Colobran, R., Condino-Neto, A., Covill, L., El Zein, L., Flores, C., Gregersen, P., Gut, M., Haerynck, F., Halwani, R., Hancerli, S., Hammarstrom, L., Hatipoglu, N., Karbuz, A., Keles, S., Kyheng, C., Leon-Lopez, R., Franco, J. L., Mansouri, D., Martinez-Picado, J., Metin Akcan, O., Migeotte, I., Morange, P.-E., Morelle, G., Martin-Nalda, A., Novelli, G., Novelli, A., Ozcelik, T., Palabiyik, F., Pan-Hammarstrom, Q., Perez de Diego, R., Planas-Serra, L., Pleguezuelo, D., Prando, C., Pujol, A., Reyes, L. F., Riviere, J., Rodriguez-Gallego, C., Rojas, J., Rovere-Querini, P., Schluter, A., Shahrooei, M., Sobh, A., Soler-Palacin, P., Tandjaoui-Lambiotte, Y., Tipu, I., Tresoldi, C., Troya, J., van de Beek, D., Zatz, M., Zawadzki, P., Al-Muhsen, S. Z., Baris-Feldman, H., Butte, M., Constantinescu, S., Cooper, M., Dalgard, C., Fellay, J., Heath, J., Lau, Y.-L., Lifton, R., Maniatis, T., Mogensen, T., von Bernuth, H., Lermine, A., Vidaud, M., Boland, A., Deleuze, J.-F., Nussbaum, R., Kahn-Kirby, A., Mentre, F., Tubiana, S., Gorochov, G., Tubach, F., Hausfater, P., Meyts, I., Zhang, S.-Y., Puel, A., Notarangelo, L., Boisson-Dupuis, S., Su, H., Boisson, B., Jouanguy, E., Casanova, J.-L., Zhang, Q., Abel, L., Cobat, A.
10.1101/2022.10.22.22281221 — Posted: 2022-10-25
Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
Matias-Guiu, J. A., Herrera, E., Gonzalez-Nosti, M., Krishnan, K., Delgado-Alonso, C., Diez-Cirarda, M., Yus, M., Martinez-Petit, A., Pagan, J., Ayala, J. L., Busch, R., Hermann, B. P.
10.1101/2022.10.21.22281239 — Posted: 2022-10-25
A SEIRD+V Model for the Effect of Vaccination and Social Distancing on SARS-CoV-2 Infection and Mortality
Sharifi, H., Jin, A. S.
10.1101/2022.10.23.22281416 — Posted: 2022-10-25
Scoping review and meta-analysis of COVID-19 epidemiological parameters for modeling from early Asian studies
Fonfria, E. S., Vigo, M. I., Garcia-Garcia, D., Herrador, Z., Navarro, M., BORDEHORE, C.
10.1101/2022.10.23.22281408 — Posted: 2022-10-25
NC-COVID: A Time-Varying Compartmental Model for Estimating SARS-CoV-2 Infection Dynamics in North Carolina, US
Delamater, P. L., Woodul, R. L.
10.1101/2022.10.21.22281271 — Posted: 2022-10-25
COVID-19 vaccine equity and the right to health for displaced Venezuelans in Latin America
Hill, D., Andrade-Romo, Z., Solari, K., Adams, E., Forman, L., Grace, D., Silva-Santisteban, A., Perez-Brumer, A.
10.1101/2022.10.21.22281363 — Posted: 2022-10-25
Comparative Effectiveness of Dexamethasone in Treatment of Hospitalized COVID-19 Patients during the First Year of the Pandemic: The N3C Data Repository
Zhou, R., Johnson, K. E., Rousseau, J. F., Rathouz, P. J., The N3C Consortium
10.1101/2022.10.22.22281373 — Posted: 2022-10-24
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants
Desautels, T. A., Arrildt, K. T., Zemla, A. T., Lau, E. Y., Zhu, F., Ricci, D., Cronin, S., Zost, S., Binshtein, E., Scheaffer, S. M., Engdahl, T. B., Chen, E., Goforth, J. W., Vashchenko, D., Nguyen, S., Weilhammer, D. R., Lo, J. K.-Y., Rubinfeld, B., Saada, E. A., Weisenberger, T., Lee, T.-H., Whitener, B., Case, J. B., Ladd, A., Silva, M. S., Haluska, R. M., Grzesiak, E. A., Bates, T. W., Petersen, B. K., Thackray, L. B., Segelke, B. W., Lillo, A. M., Sundaram, S., Diamond, M. S., Crowe, J. E., Carnahan, R. H., Faissol, D. M.
10.1101/2022.10.21.513237 — Posted: 2022-10-24
The ACE-2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion.
Cervantes, M., Hess, T., Morbioli, G. G., Sengar, A., Kasson, P. M.
10.1101/2022.10.22.513347 — Posted: 2022-10-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).